← Browse by Condition
Medical Condition
posterior capsule opacification
Total Trials
2
Recruiting Now
2
Trial Phases
Various
ClinicalMetric tracks all active clinical trials for posterior capsule opacification sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Top Sponsors
1 trial
1 trial
NCT07213167
Recruiting
Clinical Evaluation of Low Contrast Visual Performance and Low Light Phenomena in Patients With Various Intraocular Lens Implants
Enrollment
120 pts
Location
United States
Sponsor
Dr. Daniel H. Chang, MD
NCT06060041
Recruiting
IC-8 Apthera IOL New Enrollment Post Approval Study
Enrollment
435 pts
Location
United States
Sponsor
Bausch & Lomb Incorporated
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology